Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S./Canada Price Gap Closing Thanks To Generics, Express Scripts Says

Executive Summary

The difference between U.S. and Canadian prescription drug prices is narrowing in the top therapeutic categories, Express Scripts CEO Barrett Toan told the Medicare Prescription Drug Congress Feb. 26 in Washington, D.C

You may also be interested in...



Express Scripts Sees Discounts From All Rx Firms For Medicare Card

Express Scripts expects all drug manufacturers to offer "meaningful discounts" for Medicare-endorsed drug card plans, CEO Barrett Toan told the Medicare Prescription Drug Congress Feb. 26

Generics, Not Reimportation, Are Solution To High Drug Costs – McClellan

States should encourage more generic drug use - not reimportation - as a way to lower pharmacy costs, FDA Commissioner McClellan said

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

ID1132082

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel